Tazia Ann Cook, OD | |
1604 Professional Cir, Yukon, OK 73099-6314 | |
(405) 354-3624 | |
(405) 350-7512 |
Full Name | Tazia Ann Cook |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 7 Years |
Location | 1604 Professional Cir, Yukon, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750804134 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | OK2921 (Oklahoma) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Eye Care Associates Of Yukon | 1254492572 | 2 |
News Archive
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a revised clinical trial protocol.
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has received a Notice of Non-Compliance (NON) from Health Canada regarding its New Drug Submission (NDS) for Feraheme® (ferumoxytol) injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
› Verified 8 days ago
Provider Name | Eye Care Associates Of Yukon |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1831318633 PECOS PAC ID: 1254492572 Enrollment ID: O20081205000068 |
News Archive
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a revised clinical trial protocol.
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has received a Notice of Non-Compliance (NON) from Health Canada regarding its New Drug Submission (NDS) for Feraheme® (ferumoxytol) injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Tazia Ann Cook, OD 1604 Professional Cir, Yukon, OK 73099-6314 Ph: (405) 354-3624 | Tazia Ann Cook, OD 1604 Professional Cir, Yukon, OK 73099-6314 Ph: (405) 354-3624 |
News Archive
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a revised clinical trial protocol.
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has received a Notice of Non-Compliance (NON) from Health Canada regarding its New Drug Submission (NDS) for Feraheme® (ferumoxytol) injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
› Verified 8 days ago
Oklahoma Eye Specialist Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2001 Wheatfield Ave, Yukon, OK 73099 Phone: 405-308-3430 | |
Michael Joseph Hampton, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1604 Professional Cir, Yukon, OK 73099 Phone: 405-354-3624 Fax: 405-350-7512 | |
Total Optical Llc Optometrist Medicare: Medicare Enrolled Practice Location: 4400 Grant Blvd, Suite 106, Yukon, OK 73099 Phone: 405-603-4744 | |
Legacy Eye Care Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1207 Cornwell Dr, Yukon, OK 73099 Phone: 405-354-3384 | |
Dr. John Mace, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: Ultimate Vision, 334 S. Mustang Rd, Yukon, OK 73099 Phone: 405-324-0001 Fax: 405-324-0015 | |
Dr. Valerie Ridgena Hatley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 621 W Main St, Yukon, OK 73099 Phone: 405-354-2788 | |
Dr. David Charles Brewer, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1207 S Cornwell Dr, Yukon, OK 73099 Phone: 405-354-3384 Fax: 405-354-0703 |